Skip to search formSkip to main contentSkip to account menu

MK-0524

Known as: MK0524 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Indoles

Narrower (1)

laropiprant

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Assessing the agonist profiles of the prostacyclin analogues treprostinil and naxaprostene, particularly their DP₁ activity.
2014
2014
Blocking effects of PD98059, SeCl4 and MK-0524 on dexamethasone pretreatment-induced neuroprotection against hypoxic-ischemic (HI) brain injury in P10 rat pups.
2013
2013
Inverse Agonist and Pharmacochaperone Properties of MK-0524 on the Prostanoid DP1 Receptor
Prostaglandin D2 (PGD2) acts through two G protein-coupled receptors (GPCRs), the prostanoid DP receptor and CRTH2 also known as… 
2007
2007
Metabolic activation of indole-containing prostaglandin D2 receptor 1 antagonists: impacts of glutathione trapping and glucuronide conjugation on covalent binding.
2007
2007
In vitro biotransformations of the prostaglandin D2 (DP) antagonist MK-0524 and synthesis of metabolites.
2007
2007
Mechanism-Based Inactivation of Lung-Selective Cytochrome P 450 CYP 2 F Enzymes
3-Methylindole (3MI) is a pneumotoxin that requires P450-catalyzed metabolic activation (dehydrogenation), to an electrophilic… 
2006
2006
Abstract 1634: Effects of the DP1-receptor Antagonist MK-0524 on Nicotinic Acid-Induced Flushing in Lipid Clinic Patients
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)